HealthTechX Asia: Navigating Singapore’s Healthcare Market with a collaborative mindset

In this collaborative article, we pair up with HealthTechX Asia to share three key considerations for accelerating innovation in this market. The team reflect on provider-led success stories from the annual conference, which brings together the region’s leading healthcare providers, innovators and technology partners.

Interested in learning more about international opportunities for expansion? Find out about the DigitalHealth.London Global webinar programme.


Singapore is one of the most advanced health systems in Asia. It has strong digital infrastructure, a highly skilled workforce, and a government that invests heavily in innovation. Because of this, it can be a promising, yet demanding environment for innovators from the UK to deploy and scale innovation. For innovators exploring this market, there are three key considerations for accelerating innovation:

With an estimated one in four residents being over the age of 65 by 2030, Singapore’s population is ageing at one of the fastest rates in the world. This shift is increasing demand for long term conditions management, long-term care and services that support people to stay well at home.

At the same time, the government is working to keep healthcare spending sustainable. Singapore’s healthcare expenditure is roughly half that of the UK, and among the lowest in high-income countries, which shows the importance placed on efficiency.

For innovators, this means solutions must support better outcomes for older adults and help reduce system pressures. Preventive care is a national priority under the Healthier SG strategy. Tools that help people manage their health earlier, or that reduce avoidable hospital use, are well aligned with this direction.

There is also growing interest in home-based and community-based care. HealthTechX Asia has seen growing demand for patient-centred digital tools that support safe care outside hospital settings, with innovators at the Startup Theatre and Innovation Alley – two areas at the conference – pitching telehealth, remote monitoring and hybrid care models.

One of the key topics that will discussed at the upcoming HealthTechX Asia conference is Telehealth and Home Care Systems. Sessions in this theme will explore how providers are scaling telehealth, wearables and remote monitoring technologies, while addressing the infrastructure integration needed to embed these solutions into existing clinical and IT systems.

Singapore’s regulatory environment is clear and well structured. It supports innovation but also sets a high bar for safety, data protection and evidence. Both clinicians and patients expect reliable, well tested products.

Innovators need to be ready with strong clinical validation and real-world evidence. Interoperability is also important. Many public healthcare services run on national digital platforms, and new solutions need to integrate with these systems.

Partnerships can make this easier. Local accelerators, health clusters and innovation partners help international companies understand workflows, regulatory pathways and cultural expectations. At HealthTechX Asia, we explore Trust, Ethics and Regulatory Readiness, as well as how healthcare organisations are transforming data into actionable insights for transformation.

Singapore is positioning itself as a leading hub for digital health. Investment is increasing across the Asia Pacific life sciences sector, and Singapore is often the entry point for companies looking to expand into the region. This creates opportunity but also competition.

To stand out, innovators need to show clear value and local relevance. Even successful products from other markets often need adaptation for Singapore’s cultural and system context. User-centred design is becoming a key differentiator.

At HealthTechX Asia, one of our core themes is Patient-Centric and Inclusive Digital Design. This reflects a wider expectation in Singapore that products must be accessible and easy to use for diverse populations.

Singapore also rewards solutions that can scale beyond its borders. Many partners and investors look for products that can expand across Southeast Asia. Companies that can demonstrate this potential are more likely to gain traction.

Across all three considerations, one theme is consistent: collaboration is essential. Singapore’s health system values partnership, whether through co-development with patients and clinicians, work with local innovation partners, or participation in regional networks.

Recognising this, HealthTechX Asia focuses on ecosystem collaboration serving as a platform for the stakeholders such as innovators, clinicians, regulators to come together to partner and learn to shape the future of healthcare.

For UK companies, Singapore offers a strong platform for growth. Innovators who take time to understand and adapt these key considerations will have the potential to contribute to a system that is changing quickly and with purpose.


HealthTechX Asia connects stakeholders seeking innovative ways to improve efficiency and deliver better patient outcomes across the health continuum. The conference returns to Sands Expo & Convention Centre, Singapore, from Wednesday 6 May – Thursday 7 May 2026. Visit the website to find out more.


Want to get involved in the DigitalHealth.London Global programme? Get in touch with us today.